Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi
Maria Assunta Rocca

Showing results (281-290 of 1,319) with videos related to

Pageof 132
Sort By:
Annals of Neurology|March 7, 2022
Spinal Cord Atrophy Is a Preclinical Marker of Progressive MSBurcu Zeydan, Maria A Rocca, Orhun H Kantarci, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 3, 2011
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disordersFederica Agosta, Elisa Canu, Lidia Sarro, et al.
Brain : a Journal of Neurology|June 8, 2023
The coming of age of liquid biopsy in neuro-oncologyGiulia Berzero, Valentina Pieri, Pietro Mortini, et al.
Current Opinion in Oncology|July 16, 2024
Liquid biopsy in brain tumors: moving on, slowlyGiulia Berzero, Valentina Pieri, Leonardo Palazzo, et al.
Annals of Neurology|April 15, 2020
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age ParadigmJames H Cole, Joel Raffel, Tim Friede, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 2020
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approachLaura Cacciaguerra, Maria A Rocca, Loredana Storelli, et al.
European Journal of Neurology|April 14, 2021
Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadineMaria A Rocca, Paola Valsasina, Bruno Colombo, et al.
Journal of Neurology|April 18, 2003
Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR studyMaria A Rocca, Giuseppe Iannucci, Marco Rovaris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 6, 2022
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid BiomarkersMonica Margoni, Paolo Preziosa, Paola Tortorella, et al.
Journal of Neurology|December 12, 2022
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosisMatteo Albergoni, Loredana Storelli, Paolo Preziosa, et al.
Pageof 132

Showing results (281-290 of 1,319) with videos related to

Sort By:
Pageof 132
Annals of Neurology|March 7, 2022
Spinal Cord Atrophy Is a Preclinical Marker of Progressive MSBurcu Zeydan, Maria A Rocca, Orhun H Kantarci, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 3, 2011
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disordersFederica Agosta, Elisa Canu, Lidia Sarro, et al.
Brain : a Journal of Neurology|June 8, 2023
The coming of age of liquid biopsy in neuro-oncologyGiulia Berzero, Valentina Pieri, Pietro Mortini, et al.
Current Opinion in Oncology|July 16, 2024
Liquid biopsy in brain tumors: moving on, slowlyGiulia Berzero, Valentina Pieri, Leonardo Palazzo, et al.
Annals of Neurology|April 15, 2020
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age ParadigmJames H Cole, Joel Raffel, Tim Friede, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 2020
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approachLaura Cacciaguerra, Maria A Rocca, Loredana Storelli, et al.
European Journal of Neurology|April 14, 2021
Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadineMaria A Rocca, Paola Valsasina, Bruno Colombo, et al.
Journal of Neurology|April 18, 2003
Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR studyMaria A Rocca, Giuseppe Iannucci, Marco Rovaris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 6, 2022
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid BiomarkersMonica Margoni, Paolo Preziosa, Paola Tortorella, et al.
Journal of Neurology|December 12, 2022
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosisMatteo Albergoni, Loredana Storelli, Paolo Preziosa, et al.
Pageof 132